Online Formulary
Therapeutic Sections
1. Gastro-intestinal system
2. Cardiovascular system
3. Respiratory system
4. Nervous system
5. Infection
6. Endocrine system
7. Genito-Urinary System
8. Immune System and Malignant Disease
9. Blood and Nutrition
10. Musculoskeletal system
11. Eye
12. Ear, Nose and Oropharynx
13. Skin
14. Vaccines
15. Anaesthesia
16. Emergency Treatment of Poisoning
Appliances
Borderline Substances
Do Not Prescribe
Drug Monitoring in Adults in Primary Care
High Cost Drugs
Over The Counter Medication
Wound Management
Drug Index
Kent and Medway Governance
Guidance/Pathways
Therapeutic Sections Guidelines
SPS Guidance on drug monitoring in Adults in Primary Care
Shared Care Agreements
Care Home Best Practice Guidance
Do Not Prescribe - Guidelines
Over The Counter Medication - Guidelines
Prescribing & General Guidelines
Palliative Care Guidance
How to use your Inhaler
Covid 19 Guidance
Lost / Stolen Prescriptions
Newsletters & Alerts
Kent & Medway Medicines Optimisation Newsletter
Supply Shortages Alerts - Kent & Medway
MHRA Drug Safety Updates
NICE Publications News
Archive
Using the Formulary
Therapeutic Sections
1. Gastro-intestinal system
1.1. Chronic bowel disorders
1.1.1 Aminosalicylates
1.1.2 Corticosteroids
1.1.3 Immunosuppressants
1.1.4 Irritable bowel syndrome
1.2. Constipation and bowel cleansing
1.2.1. Bowel cleansing
1.2.2. Constipation
1.3. Diarrhoea
1.4. Disorders of gastric acid and ulceration
1.4.1 Antacids
1.4.2 Helicobacter pylori eradication
1.4.3 Gastroprotective chelates and complexes
1.4.4 H2-receptor antagonists
1.4.5 Proton Pump Inhibitors
1.5 Gastro-intestinal smooth muscle spasm
1.6. Liver disorders and related conditions
1.6.1. Biliary disorders
1.6.2. Oesophageal varices
1.7 Obesity
1.8 Rectal and anal disorders
1.8.1. Anal fissures
1.8.2. Haemorrhoids
1.9 Reduced exocrine secretions
1.10 Disorders of the Oesophagus
2. Cardiovascular system
2.1. Arrhythmias
2.2. Bleeding disorders
2.2.1 Antifibrinolytic drugs and haemostatics
2.2.2 Subarachnoid haemorrhage
2.3. Blood clots
2.3.1. Blocked Catheters and Lines
2.3.2. Thromboembolism
2.4. Blood pressure conditions
2.4.1. Hypertension
2.4.2. Hypotension and shock
2.5. Heart failure
2.5.1. Potassium-Sparing Diuretics (Aldosterone antagonists)
2.5.2. Drugs Acting on the Renin-Angiotensin System
2.5.3. SGLT2 inhibitor (Heart Failure)
2.6. Hyperlipidaemia
2.7. Myocardial ischaemia
2.7.1 Antithrombotic Drugs
2.7.2 Nitrates
2.7.3 Other antianginal drugs
2.7.4 Sympathomimetics
2.8. Oedema
2.8.1 Loop Diuretics
2.8.2 Potassium-Sparing Diuretics
2.8.3 Osmotic Diuretics
2.9. Vascular disease
2.9.1 Peripheral vascular disease
2.9.2 Vein malformations
3. Respiratory system
3.1. Airways disease, obstructive
3.1.1 Antimuscarinics
3.1.2 Beta-2 adrenoreceptor agonists - long acting
3.1.3 Beta-2 adrenoreceptor agonists - short acting
3.1.4 Corticosteroids (inhaled)
3.1.5 Immunosuppressants (Monoclonal Antibodies)
3.1.6 Leukotriene receptor antagonists
3.1.7 Mast Cell Stabilisers (Cromoglicate and related therapy)
3.1.8 Vasoconstrictor sympathomimetics
3.1.9 Phosphodiesterase Type-4 Inhibitor
3.1.10 Xanthines
3.1.11 Peak Flow meters and spacer devices
3.2. Allergic conditions- Antihistamines, Hyposensitisation and Allergic Emergencies
3.2.1 Antihistamines - non-sedating
3.2.2 Antihistamines - sedating
3.2.3 Allergen-Type Vaccines
3.2.4 Allergic Emergencies
3.3. Conditions affecting sputum viscosity
3.3.1 Mucolytics
3.3.2. Cystic fibrosis
3.4. Cough and congestion
3.5. Idiopathic pulmonary fibrosis
3.6 Respiratory stimulants
4. Nervous system
4.1. Dementia
4.2. Epilepsy and other seizure disorders
4.2.1 Epilepsy and other seizure disorders
4.2.2. Status epilepticus
4.3. Mental health disorders
4.3.1. Anxiety
4.3.2. Attention deficit hyperactivity disorder
4.3.3. Bipolar disorder and mania
4.3.4. Depression
4.3.5. Inappropriate sexual behaviour
4.3.6. Psychoses and schizophrenia
4.4. Movement disorders
4.4.1. Dystonias and other involuntary movements
4.4.2. Parkinson's disease
4.5. Nausea and labyrinth disorders
4.5.1 Antiemetics and Antinauseants
4.5.2 Meniere's disease
4.6. Pain
4.6.1 Analgesics
4.6.2.. Migraine and Headache
4.6.3 Neuropathic pain
4.7. Sleep disorders
4.7.1. Insomnia
4.7.2. Narcolepsy
4.8. Substance dependence
4.8.1. Alcohol dependence
4.8.2. Nicotine dependence
4.8.3. Opioid dependence
5. Infection
5.1 Bio-Kult
5.2 Rifaximin
5.3 Peginterferon Alfa
5.4 Other Antibacterials
5.5 Antiviral Drugs
5.5.1 COVID-19
5.5.2 Viral Hepatitis
6. Endocrine system
6.1 Antidiuretic hormone disorders
6.1.1. Diabetes insipidus
6.1.2. Syndrome of inappropriate antidiuretic hormone secretion
6.2. Corticosteroid responsive conditions
6.2.1 Glucocorticoid therapy
6.2.2 Replacement therapy
6.2.3 Cushing's syndrome and disease
6.3. Diabetes mellitus and hypoglycaemia
6.3.1. Diabetes mellitus
6.3.2. Hypoglycaemia
6.3.3 Diabetes, diagnostics and monitoring
6.4. Disorders of bone metabolism
6.4.1 Bisphosphonates
6.4.2 Calcium Regulating Drugs
6.4.3 Drugs Affecting Bone Structure and Mineralisation
6.5. Dopamine responsive conditions
6.6. Gonadotrophin responsive conditions
6.6.1 Hereditary angioedema
6.6.2 Pituitary and Hypothalamic Hormones and Analogues
6.7. Hypothalamic and anterior pituitary hormone related disorders
6.7.1. Adrenocortical function testing
6.7.2. Assessment of pituitrary function
6.7.3. Gonadotrophin replacement therapy
6.7.4. Growth hormone disorders
6.8. Sex hormone responsive conditions
6.8.1. Female sex hormone responsive conditions
6.8.2. Male sex hormone responsive conditions
6.9. Thyroid disorders
6.9.1. Hyperthyroidism
6.9.2. Hypothyroidism
7. Genito-Urinary System
7.1. Bladder and Urinary Disorders
7.1.1. Urinary Frequency, Enuresis, and Incontinence
7.1.2. Urinary Retention
7.1.3. Urological Pain
7.2. Bladder Instillations and Urological Surgery
7.3. Contraception
7.3.1. Contraception, combined
7.3.2. Contraception, devices
7.3.3. Contraception, emergency
7.3.4. Contraception, oral progestogen-only
7.3.5. Contraception, parenteral progestogen-only
7.3.6. Contraception, spermicidal
7.4. Erectile and Ejaculatory Condition
7.4.1. Erectile Dysfunction
7.4.2. Premature Ejaculation
7.5. Obstetrics
7.5.1. Induction of Labour
7.5.2. Postpartum Haemorrhage
7.5.3. Premature Labour
7.5.4. Termination of Pregnancy
7.5.5 Treatment of Fibroids
7.6. Vaginal and vulval conditions
7.6.1 Vaginal and vulval changes
7.6.2. Vaginal and vulval infections
7.6.3 Vaginal Atrophy
8. Immune System and Malignant Disease
8.1 Cytotoxic drugs
8.1.1 Treatment of Cytotoxic Drug Induced Side Effects
8.2 Drugs affecting the immune response
8.2.1 Antiproliferative immunosuppressants
8.2.2 Corticosteroids and other immunosuppressants
8.2.3 Other immunomodulating drugs
8.3 Sex hormones and hormone antagonists in malignant disease
8.3.1 Oestrogens
8.3.2 Progestogens
8.3.3 Hormone antagonists
8.4 Antibody Responsive Malignancy
9. Blood and Nutrition
9.1 Anaemias and other blood disorders
9.1.1 Anaemias
9.1.2. Iron Overload
9.1.3. Neutropenia
9.1.4. Platelet Disorders
9.2 Nutrition and Metabolic Disorders
9.2.1. Fluid and Electrolyte Imbalance
9.2.2. Calcium Imbalance
9.2.3. Low Blood Volume
9.2.4. Magnesium Imbalance
9.2.5. Phosphate Imbalance
9.2.6. Potassium Imbalance
9.3. Metabolic Disorders
9.3.1. Carnitine Deficiency
9.4. Mineral and Trace Elements Deficiencies
9.4.1. Zinc Deficiency
9.5 Nutrition
9.5.1 Intravenous Nutrition
9.5.2 Enteral Nutrition
9.5.3 Oral Nutritional Supplements
9.5.4 Special Diets
9.5.5 Specialised Infant Formula
9.6. Vitamin Deficiencies
9.6.1. Vitamin B Group
9.6.2. Vitamin C
9.6.3. Vitamin D
9.6.4 Vitamin E
9.6.5 Vitamin K
9.6.6. Multivitamin Preparations
10. Musculoskeletal system
10.1. Arthritis
10.1.1 Disease-Modifying Anti-Rheumatic Drugs
10.1.2 Phosphodiesterase Type-4 Inhibitors
10.1.3 Immunosuppressants
10.2. Hyperuricaemia and Gout
10.2.1 Alkaloids
10.2.2 Xanthine Oxidase Inhibitors
10.3. Neuromuscular Disorders
10.3.2. Myasthenia Gravis and Lamber-Eaton Myasthenic Syndrome
10.3.3. Nocturnal Leg Cramps
10.3.4. Spasticity
10.4. Pain and Inflammation in Musculoskeletal Disorders
10.5. Soft Tissue and Joint Disorders
11. Eye
11.1. Allergic and Inflammatory Eye Conditions
11.1.1. Allergic Conjunctivitis
11.1.2. Inflammatory Eye Conditions
11.1.3 Anterior Uveitis
11.2. Dry Eye Conditions
11.3. Eye Infections
11.3.1. Bacterial Eye Infections
11.3.2 Opthalmic Herpes Simplex
11.4. Eye Procedures
11.4.1 Mydriatics and Cycliplegics
11.4.2 Post-operative Pain and Inflammation
11.5. Glucoma and Ocular Hypertension
11.5.1 Beta-adrenoceptor blockers
11.5.2 Carbonic Anhydrase Inhibitors
11.5.3 Prostglandin Analogues and Prostamides
11.5.4 Sympathomimetics
11.6. Retinal Disorders
12. Ear, Nose and Oropharynx
12.1. Ear
12.1.1 Otitis Externa
12.1.2 Removal of Earwax
12.1.3 Acute Otitis media
12.2. Nose
12.2.1. Nasal Congestion
12.2.2. Nasal Infection
12.2.3. Nasal Inflammation, Nasal Polyps and Rhinitis
12.3. Oropharynx
12.3.1. Dry Mouth
12.3.2. Oral Hygiene
12.3.3. Oral Ulceration and Inflammation
12.3.4. Oropharyngeal Bacterial Infections
12.3.5. Oropharyngeal Fungal Infections
12.3.6. Oropharyngeal Viral Infections
13. Skin
13.1. Dry and Scalling Skin Disorders
13.1.1 Emollient creams and ointments, Paraffin-containing
13.1.2 Emollient creams and ointments, antimicrobial-containing
13.1.3 Emollient creams and ointments, oatmeal-containing
13.1.4 Emollients, Urea-containing
13.1.5 Barrier Creams and Ointments
13.2. Infections of the Skin
13.2.1. Bacterial Skin Infections
13.2.2. Fungal Skin Infections
13.2.3. Parasitic Skin Infections
13.2.4. Viral Skin Infections
13.3. Inflammatory Skin Conditions
13.3.1. Eczema and Psoriasis
13.4. Perspiration
13.5. Pruritus
13.6. Rosacea and Acne
13.6.1. Acne
13.6.2. Rosacea
13.7. Scalp and Hair Conditions
13.7.1. Alopecia
13.7.2. Hirsutism
13.7.3 Antiseptics and Disinfectants
13.7.4 Vitamins and Trace Elements
13.8. Skin Cleansers, Antiseptics and Desloughing Agents
13.8.1 Antiseptics and Disinfectants
13.8.2. Minor Cuts and Abrasions
13.9. Skin Disfigurements
13.10 Sun Protection and Photodamage
13.11. Superficial Soft-Tissue Injuries and Superficial Thromobophlebitis
13.12. Warts and Calluses
13.12.1 Antineoplastic Drugs
13.12.2 Antiseptics and Disinfectants
13.12.3 Antivirals
13.12.4 Salicylic Acid and Derivatives
14. Vaccines
15. Anaesthesia
15.1. General Anaesthesia
15.1.1. Anaesthetic Adjuvants
15.1.2. Malignant Hyperthermia
15.2. Local Anaesthesia
15.3 Sedatives
16. Emergency Treatment of Poisoning
16.1. Active Elimination From The GI Tract
16.2. Chemical Toxicity
16.2.1. Cyanide Toxicity
16.2.2. Organophosphorus Toxicity
16.3. Drug Toxicity
16.3.1. Benozdiazepine Toxicity
16.3.2. Digoxin Toxicity
16.3.3. Heparin Toxicity
16.3.4. Opioid Toxicity
16.3.5. Paracetamol Toxicity
16.4. Methaemoglobinaemia
16.5. Snake Bites
Appliances
Continence
Stoma
Borderline Substances
High-energy Supplements: Protein
Feed Thickeners and Pre-thickened Drinks
Food for Special Diets
Gluten Free
Specialised Infant Formula
Oral Nutritional Supplements (SIP Feeds)
Do Not Prescribe
Drug Monitoring in Adults in Primary Care
High Cost Drugs
Over The Counter Medication
Wound Management
Medway Only
Swale Only
Drug Index
Kent and Medway Governance
Guidance/Pathways
Therapeutic Sections Guidelines
1. Gastro-intestinal system - guidance
2. Cardiovascular system - guidance
3. Respiratory system - guidance
4. Nervous system - guidance
5. Infection - guidance
6. Endocrine system - guidance
7. Genito-Urinary System - guidance
8. Immune System and Malignant Disease - guidance
9. Blood and Nutrition - guidance
10. Musculoskeletal system - guidance
11. Eye - guidance
12. Ear, Nose and Oropharynx - guidance
13. Skin - guidance
14. Vaccines - guidance
15. Anaesthesia - guidance
16. Emergency Treatment of Poisoning - guidance
Appliances - guidance
Borderline Substances - guidance
Wound Management - guidance
SPS Guidance on drug monitoring in Adults in Primary Care
Shared Care Agreements
Care Home Best Practice Guidance
Do Not Prescribe - Guidelines
Over The Counter Medication - Guidelines
Prescribing & General Guidelines
Palliative Care Guidance
How to use your Inhaler
Covid 19 Guidance
Lost / Stolen Prescriptions
Newsletters & Alerts
Kent & Medway Medicines Optimisation Newsletter
2024 Kent & Medway Medicines Optimisation Newsletters
2023 Kent & Medway Medicines Optimisation Newsletters
2022 Kent & Medway Medicines Optimisation Newsletters
2021 Kent & Medway Medicines Optimisation Newsletters
2020 Kent & Medway Medicines Optimisation Newsletters
Supply Shortages Alerts - Kent & Medway
MHRA Drug Safety Updates
NICE Publications News
Archive
Medway Newsletters 2019-2020
Swale Newsletters 2019-2020
COVID Kent & Medway Newsletters
Care Homes Newsletters - Medway & Swale
7.5.4.2 Prostaglandins and Oxytocics
Misoprostol
Misoprostol 200microgram tablets
Pack
140 tablet
40 tablet
42 tablet
56 tablet
60 tablet
Gemeprost
Gemeprost 1mg pessaries
Pack
5 pessary
First Line Choice
On Formulary
Specialist Initiation Only
Hospital Only
KMPT Initiation Only
